Suivre
Vassiki Sanogo
Vassiki Sanogo
Pharmacoevidence, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey
Aucune adresse e-mail validée
Titre
Citée par
Citée par
Année
A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
V Diaby, R Tawk, V Sanogo, H Xiao, AJ Montero
Breast câncer research and treatment 151, 27-40, 2015
1522015
Financial reforms, financial development, and economic growth in the Ivory Coast
V Sanogo, RK Moussa
Economies 5 (1), 7, 2017
232017
ELICIT: An alternative imprecise weight elicitation technique for use in multi-criteria decision analysis for healthcare
V Diaby, V Sanogo, KR Moussa
Expert review of pharmacoeconomics & outcomes research 16 (1), 141-147, 2016
192016
A quantitative analysis of the effect of continuity of care on 30-day readmission and in-hospital mortality among patients with acute ischemic stroke
AN Okere, V Sanogo, R Balkrishnan, V Diaby
Journal of Stroke and Cerebrovascular Diseases 29 (9), 105053, 2020
92020
Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a …
AN Okere, V Sanogo, H Alqhtani, V Diaby
Expert review of pharmacoeconomics & outcomes research 21 (5), 1043-1048, 2021
62021
Economic impact of the passage of the medical marijuana law in the state of Florida
V Diaby, V Sanogo, H Xiao, X Zhong, J Dykes, C Judson
Available at SSRN 3265254, 2018
32018
Cocoa Sector in Côte D’Ivoire: Are Public-Private Coordination Platforms Helpful
D Kanga, R Moussa, V Sanogo
CSAE Conference, 2019
22019
Elicitation of determinants of rural households’ water supply in Côte d’Ivoire: A case study
V Sango
Proceedings of the 7th RWSN Forum “Water for Everyone”, Abidjan, Côte d …, 0
2
Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014
Z Chen, A Babcock, V Sanogo, DR Nelson, H Xiao, V Diaby
Expert Review of Pharmacoeconomics & Outcomes Research 22 (3), 409-415, 2022
12022
EE655 Patients Level Cost of Treating Adverse Events in Alzheimer’s Disease for US-FDA Approved Treatments
V Sanogo, R Almutairi, K Diaby
Value in Health 26 (12), S179-S180, 2023
2023
EE500 An Overview of Systematic Literature Review of Economic Evaluation of Treatment on Patients With Alzheimer's Disease and Related Dementia
V Sanogo, R Almutairi, K Diaby
Value in Health 26 (12), S147, 2023
2023
EE350 Budget Impact of Memantine for Alzheimer's Patient in the United States
R Almutairi, V Sanogo, K Diaby
Value in Health 26 (12), S118, 2023
2023
EPH75 Adverse Event Types and Discontinuation Rate of Alzheimer's Medication Approved by United States Food and Drug Administration (USFDA)
R Almutairi, V Sanogo, K Diaby
Value in Health 26 (12), S216, 2023
2023
CO51 Safety Profile of Approved Alzheimer's Medication By USFDA
R Almutairi, V Sanogo, K Diaby
Value in Health 26 (12), S23, 2023
2023
EE134 An Overview of Systematic Literature Review of Economic Evaluation of Treatment on Patients with Alzheimer’s Disease and Related Dementia
V Diaby, R Almutairi, V Sanogo
Value in Health 26 (6), S84, 2023
2023
Predictors of 30-day readmission, mortality, and length of stay for hospitalized U.S. patients with Alzheimer’s and related dementias from 2010 to 2015
V Sanogo, Z Chen, RD Almutairi, H Xiao, V & Diaby
Expert Review of Pharmacoeconomics & Outcomes Research, https://doi.org/10 …, 2023
2023
The Potential Effects of Implementing an Antibiotic Stewardship Program by Integrating It with Medication Therapy Service in a Low-Income Serving Clinic - A Single-Center …
AN Okere, ML Trimble, V Sanogo, U Smith, C Brown, SG Buxbaum
INNOVATIONS in pharmacy 13 (3), 2022
2022
PND43 Predictors of 30-Day Readmission and Hospitalization Costs of Patients with Hepatic Encephalopathy in the US from 2010 to 2014
Z Chen, A Babcock, V Sanogo, H Xiao, V Diaby
Value in Health 24, S167, 2021
2021
PMU26 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN THE UNITED STATES: A NATIONWIDE …
V Sanogo, Z Chen, H Xiao, K Diaby
Value in Health 22, S254, 2019
2019
PND11 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH HEPATIC ENCEPHALOPATHY IN THE UNITED STATES: A NATIONWIDE STUDY
Z Chen, H Xiao, K Diaby, V Sanogo
Value in Health 22, S271-S272, 2019
2019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20